Regulation of stem cell differentiation in adipose tissue by chronic inflammation

Clinical and Experimental Pharmacology and Physiology

Volumn 38, Issue 12, 2011, Pages 872-878

  Ye, Jianping ^a   Gimble, Jeffery M ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Adipocytes; Adipose tissue; Adipose derived stem cell; Cell differentiation; Endothelial cells; Inflammation; Obesity

Indexed keywords

ANGIOGENIC FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; MEMBRANE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLATELET DERIVED GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; CELL DIFFERENTIATION; ENDOTHELIUM CELL; FIBROBLAST; HUMAN; HYPOXEMIA; INFLAMMATION; MICROENVIRONMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PERICYTE; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; STEM CELL EXPANSION; TISSUE OXYGENATION;

ADIPOGENESIS; ADIPOSE TISSUE; ANIMALS; CELL HYPOXIA; CHRONIC DISEASE; ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; MICE; OBESITY; PPAR GAMMA; RATS; RATS, ZUCKER; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 82355183512     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2011.05596.x     Document Type: Review

References (88)

1. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860-7.
2. Peraldi P, Spiegelman B. TNF-alpha and insulin resistance. Summary and future prospects. Mol. Cell. Biochem. 1998; 182: 169-75.
3. Yuan M, Konstantopoulos N, Lee J et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 2001; 293: 1673-7.
4. Kim JK, Kim YJ, Fillmore JJ et al. Prevention of fat-induced insulin resistance by salicylate. J. Clin. Invest. 2001; 108: 437-46.
5. Itani SI, Ruderman NB, Schmieder F, Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 2002; 51: 2005-11.
6. Lazar MA. How obesity causes diabetes: Not a tall tale. Science 2005; 307: 373-5.
7. Rajala MW, Scherer PE. Minireview. The adipocyte: At the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 2003; 144: 3765-73.
8. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest. 2006; 116: 1784-92.
9. Kahn BB, Flier JS. Obesity and insulin resistance. J. Clin. Invest. 2000; 106: 473-81.
10. Xu H, Barnes GT, Yang Q et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 2003; 112: 1821-30.
11. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003; 112: 1796-808.
12. Takahashi K, Mizuarai S, Araki H et al. Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice. J. Biol. Chem. 2003; 278: 46654-60.
13. Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001; 414: 799-806.
14. White MF. IRS proteins and the common path to diabetes. Am. J. Physiol. Endocrinol. Metab. 2002; 283: E413-22.
15. Ye J. Role of insulin in the pathogenesis of free fatty acid-induced insulin resistance in skeletal muscle. Endocr. Metab. Immune Disord. Drug Targets 2007; 7: 65-74.
16. Ye J, Keller J. Regulation of energy metabolism by inflammation: A feedback response in obesity and calorie restriction. Aging 2010; 2: 361-8.
17. Tang T, Zhang J, Yin J et al. Uncoupling of inflammation and insulin resistance by NF-kB in transgenic mice through induction of energy expenditure. J. Biol. Chem. 2010; 285: 4637-44.
18. Pang C, Gao Z, Yin J, Zhang J, Jia W, Ye J. Macrophage infiltration into adipose tissue may promote angiogenesis for adipose tissue remodeling in obesity. Am. J. Physiol. Endocrinol. Metab. 2008; 295: E313-22.
19. Ye J. Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int. J. Obes. 2009; 33: 54-66.
20. Rajamaki K, Lappalainen J, Oorni K et al. Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: A novel link between cholesterol metabolism and inflammation. PLoS ONE 2010; 5: E11765.
21. Stienstra R, Joosten LA, Koenen T et al. The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab. 2010; 12: 593-605.
22. Wen H, Gris D, Lei Y et al. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat. Immunol. 2011; 12: 408-15.
23. Vandanmagsar B, Youm YH, Ravussin A et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 2011; 17: 179-88.
24. Trayhurn P, Wang B, Wood IS. Hypoxia in adipose tissue. A basis for the dysregulation of tissue function in obesity? Br. J. Nutr. 2008; 100: 227-35.
25. Hosogai N, Fukuhara A, Oshima K et al. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 2007; 56: 901-11.
26. Ye J, Gao Z, Yin J, He H. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am. J. Physiol. Endocrinol. Metab. 2007; 293: E1118-28.
27. Pasarica M, Sereda OR, Redman LM et al. Reduced adipose tissue oxygenation in human obesity: Evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response. Diabetes 2009; 58: 718-25.
28. Koumenis C, Naczki C, Koritzinsky M et al. Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2alpha. Mol. Cell. Biol. 2002; 22: 7405-16.
29. Zhang L, Ebenezer PJ, Dasuri K et al. Aging is associated with hypoxia and oxidative stress in adipose tissue: Implications for adipose function. Am. J. Physiol. Endocrinol. Metab. 2011; 301: E599-607.
30. Yin J, Gao Z, He Q, Ye J. Role of hypoxia in obesity-induced disorders of glucose and lipid metabolism in adipose tissue. Am. J. Physiol. Endocrinol. Metab. 2009; 296: E333-42.
31. Chen B, Lam KS, Wang Y et al. Hypoxia dysregulates the production of adiponectin and plasminogen activator inhibitor-1 independent of reactive oxygen species in adipocytes. Biochem. Biophys. Res. Commun. 2006; 341: 549-56.
32. Grosfeld A, Andre J, Hauguel-De Mouzon S, Berra E, Pouyssegur J, Guerre-Millo M. Hypoxia-inducible factor 1 transactivates the human leptin gene promoter. J. Biol. Chem. 2002; 277: 42953-7.
33. Larsen OA, Lassen NA, Quaade F. Blood flow through human adipose tissue determined with radioactive xenon. Acta Physiol. Scand. 1966; 66: 337-45.
34. Crandall DL, Goldstein BM, Huggins F, Cervoni P. Adipocyte blood flow: Influence of age, anatomic location, and dietary manipulation. Am. J. Physiol. 1984; 247: R46-51.
35. West DB, Prinz WA, Francendese AA, Greenwood MR. Adipocyte blood flow is decreased in obese Zucker rats. Am. J. Physiol. 1987; 253: R228-33.
36. Bolinder J, Kerckhoffs DA, Moberg E, Hagstrom-Toft E, Arner P. Rates of skeletal muscle and adipose tissue glycerol release in nonobese and obese subjects. Diabetes 2000; 49: 797-802.
37. Kampf C, Bodin B, Kallskog O, Carlsson C, Jansson L. Marked increase in white adipose tissue blood perfusion in the type 2 diabetic GK rat. Diabetes 2005; 54: 2620-7.
38. Jansson PA, Larsson A, Lonnroth PN. Relationship between blood pressure, metabolic variables and blood flow in obese subjects with or without non-insulin-dependent diabetes mellitus. Eur. J. Clin. Invest. 1998; 28: 813-8.
39. Karpe F, Fielding BA, Ilic V, Macdonald IA, Summers LK, Frayn KN. Impaired postprandial adipose tissue blood flow response is related to aspects of insulin sensitivity. Diabetes 2002; 51: 2467-73.
40. 2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation. Nat. Med. 1997; 3: 177-82.
41. Bluher M, Wilson-Fritch L, Leszyk J, Laustsen PG, Corvera S, Kahn CR. Role of insulin action and cell size on protein expression patterns in adipocytes. J. Biol. Chem. 2004; 279: 31902-9.
42. Halberg N, Khan T, Trujillo ME et al. HIF 1 alpha induces fibrosis and insulin resistance in white adipose tissue. Mol. Cell. Biol. 2009; 29: 4467-83.
43. Gealekman O, Guseva N, Hartigan C et al. Depot-specific differences and insufficient subcutaneous adipose tissue angiogenesis in human obesity. Circulation 2011; 123: 186-94.
44. Greenberg JI, Shields DJ, Barillas SG et al. A role for VEGF as a negative regulator of pericyte function and vessel maturation. Nature 2008; 456: 809-13.
45. Goossens GH, McQuaid SE, Dennis AL et al. Angiotensin II. A major regulator of subcutaneous adipose tissue blood flow in humans. J. Physiol. 2006; 571: 451-60.
46. Greenstein AS, Khavandi K, Withers SB et al. Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation 2009; 119: 1661-70.
47. Gao X, Belmadani S, Picchi A et al. Tumor necrosis factor-alpha induces endothelial dysfunction in Lepr (db) mice. Circulation 2007; 115: 245-54.
48. Zimmerlin L, Donnenberg VS, Pfeifer ME et al. Stromal vascular progenitors in adult human adipose tissue. Cytometry A 2010; 77: 22-30.
49. Mitchell JB, McIntosh K, Zvonic S et al. Immunophenotype of human adipose-derived cells: Temporal changes in stromal-associated and stem cell-associated markers. Stem Cells 2006; 24: 376-85.
50. Duffaut C, Galitzky J, Lafontan M, Bouloumie A. Unexpected trafficking of immune cells within the adipose tissue during the onset of obesity. Biochem. Biophys. Res. Commun. 2009; 384: 482-5.
51. Duffaut C, Zakaroff-Girard A, Bourlier V et al. Interplay between human adipocytes and T lymphocytes in obesity: CCL20 as an adipochemokine and T lymphocytes as lipogenic modulators. Arterioscler. Thromb. Vasc. Biol. 2009; 29: 1608-14.
52. Arner E, Westermark PO, Spalding KL et al. Adipocyte turnover: Relevance to human adipose tissue morphology. Diabetes 2010; 59: 105-9.
53. Cinti S, Mitchell G, Barbatelli G et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J. Lipid Res. 2005; 46: 2347-55.
54. Strissel KJ, Stancheva Z, Miyoshi H et al. Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes 2007; 56: 2910-8.
55. Yun Z, Maecker HL, Johnson RS, Giaccia AJ. Inhibition of PPAR gamma 2 gene expression by the HIF-1-regulated gene DEC1/Stra13: A mechanism for regulation of adipogenesis by hypoxia. Dev. Cell 2002; 2: 331-41.
56. Ye J. Adipose tissue vascularization: Its role in chronic inflammation. Curr. Diab. Rep. 2011; 11: 203-10.
57. Gimble J, Guilak F. Adipose-derived adult stem cells: Isolation, characterization, and differentiation potential. Cytotherapy 2003; 5: 362-9.
58. Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ. Res. 2007; 100: 1249-60.
59. Ruiz JC, Ludlow JW, Sherwood S, Yu G, Wu X, Gimble JM. Differentiated human adipose-derived stem cells exhibit hepatogenic capability in vitro and in vivo. J. Cell. Physiol. 2010; 225: 429-36.
60. Zuk PA, Zhu M, Mizuno H et al. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng. 2001; 7: 211-28.
61. Zuk PA, Zhu M, Ashjian P et al. Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell 2002; 13: 4279-95.
62. Guilak F, Lott KE, Awad HA et al. Clonal analysis of the differentiation potential of human adipose-derived adult stem cells. J. Cell. Physiol. 2006; 206: 229-37.
63. Meliga E, Strem BM, Duckers HJ, Serruys PW. Adipose-derived cells. Cell Transplant. 2007; 16: 963-70.
64. Bakker AH, Nijhuis J, Buurman WA, van Dielen FM, Greve JW. Low number of omental preadipocytes with high leptin and low adiponectin secretion is associated with high fasting plasma glucose levels in obese subjects. Diabetes Obes. Metab. 2006; 8: 585-8.
65. Fischer LJ, McIlhenny S, Tulenko T et al. Endothelial differentiation of adipose-derived stem cells: Effects of endothelial cell growth supplement and shear force. J. Surg. Res. 2009; 152: 157-66.
66. Shaked Y, Ciarrocchi A, Franco M et al. Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors. Science 2006; 313: 1785-7.
67. Amos PJ, Shang H, Bailey AM, Taylor A, Katz AJ, Peirce SM. IFATS collection: The role of human adipose-derived stromal cells in inflammatory microvascular remodeling and evidence of a perivascular phenotype. Stem Cells 2008; 26: 2682-90.
68. Crisan M, Huard J, Zheng B et al. Purification and culture of human blood vessel-associated progenitor cells. In: Elefantry A, Patient R, Schlaeger T, Snyder E, Yamashita Y (eds). Curr. Protoc. Stem Cell Biol. John Wiley & Son, Inc., Hoboken. 2008; Ch. 2.
69. Zannettino AC, Paton S, Arthur A et al. Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. J. Cell. Physiol. 2008; 214: 413-21.
70. Traktuev DO, Prater DN, Merfeld-Clauss S et al. Robust functional vascular network formation in vivo by cooperation of adipose progenitor and endothelial cells. Circ. Res. 2009; 104: 1410-20.
71. Traktuev DO, Merfeld-Clauss S, Li J et al. A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circ. Res. 2008; 102: 77-85.
72. Daquinag AC, Zhang Y, Kolonin MG. Vascular targeting of adipose tissue as an anti-obesity approach. Trends Pharmacol. Sci. 2011; 32: 300-7.
73. Rupnick MA, Panigrahy D, Zhang CY et al. Adipose tissue mass can be regulated through the vasculature. Proc. Natl Acad. Sci. USA 2002; 99: 10730-5.
74. Kolonin MG, Saha PK, Chan L, Pasqualini R, Arap W. Reversal of obesity by targeted ablation of adipose tissue. Nat. Med. 2004; 10: 625-32.
75. Ye J. Regulation of PPARγ function by TNF-α. Biochem. Biophys. Res. Commun. 2008; 374: 405-8.
76. Jaworski K, Sarkadi-Nagy E, Duncan RE, Ahmadian M, Sul HS. Regulation of triglyceride metabolism. IV. Hormonal regulation of lipolysis in adipose tissue. Am. J. Physiol. Gastrointest. Liver Physiol. 2007; 293: G1-4.
77. Suzawa M, Takada I, Yanagisawa J et al. Cytokines suppress adipogenesis and PPAR-gamma function through the TAK1/TAB 1/NIK cascade. Nat. Cell Biol. 2003; 5: 224-30.
78. Gao Z, He Q, Peng B, Chiao PJ, Ye J. Regulation of nuclear translocation of HDAC3 by IkBa is required for tumor necrosis factor inhibition of peroxisome proliferator-activated receptor {gamma} function. J. Biol. Chem. 2006; 281: 4540-7.
79. Ruan H, Hacohen N, Golub TR, Van Parijs L, Lodish HF. Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: Nuclear factor-kappaB activation by TNF-alpha is obligatory. Diabetes 2002; 51: 1319-36.
80. Kudo M, Sugawara A, Uruno A, Takeuchi K, Ito S. Transcription suppression of peroxisome proliferator-activated receptor gamma2 gene expression by tumor necrosis factor alpha via an inhibition of CCAAT/enhancer-binding protein delta during the early stage of adipocyte differentiation. Endocrinology 2004; 145: 4948-56.
81. Van Antwerp DJ, Martin SJ, Verma IM, Green DR. Inhibition of TNF-induced apoptosis by NF-kappa B. Trends Cell Biol. 1998; 8: 107-11.
82. Baud V, Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 2001; 11: 372-7.
83. Hayden MS, Ghosh S. Shared principles in NF-[kappa]B signaling. Cell 2008; 132: 344-62.
84. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination. The control of NF-[kappa]B activity. Annu. Rev. Immunol. 2000; 18: 621-63.
85. Engelman JA, Lisanti MP, Scherer PE. Specific inhibitors of p38 mitogen-activated protein kinase block 3T3-L1 adipogenesis. J. Biol. Chem. 1998; 273: 32111-20.
86. Puigserver P, Rhee J, Lin J et al. Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARgamma coactivator-1. Mol. Cell 2001; 8: 971-82.
87. Yang TT, Xiong Q, Enslen H, Davis RJ, Chow CW. Phosphorylation of NFATc4 by p38 mitogen-activated protein kinases. Mol. Cell. Biol. 2002; 22: 3892-904.
88. Hata K, Nishimura R, Ikeda F et al. Differential roles of Smad1 and p38 kinase in regulation of peroxisome proliferator-activating receptor gamma during bone morphogenetic protein 2-induced adipogenesis. Mol. Biol. Cell 2003; 14: 545-55.